However, it is still under debate whether this is a consequence of massive APP overexpression and Aβ production leading to rapid plaque formation and nucleation in neocortical areas, which might not be representative for how Aβ pathology is initiated in human AD. The gene discussed is APP; the disease is Alzheimer disease.